Azitra (AZTR)

• Market cap: $3.16M
• 1 day: 5.01%
• 5 days: -7.57%
• 1 month: -11.70%
• 3 months: -24.55%
• 6 months: -90.28%
• Year to date: -98.68%
• 1 year: -98.94%
• 5 years: -99.72%
• 10 years: -99.72%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

Employees: 10

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

8% more capital invested

Capital invested by funds: $58.5K [Q2] → $62.9K (+$4.48K) [Q3]

0.27% less ownership

Funds ownership: 2.07% [Q2] → 1.8% (-0.27%) [Q3]

13% less funds holding

Funds holding: 8 [Q2] → 7 (-1) [Q3]

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3